Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management.

Journal: European journal of nuclear medicine and molecular imaging

Published Date: Nov 1, 2021

Abstract

PURPOSE: The aim of this narrative review is to give an overview on current and emerging imaging methods and liquid biopsy for prediction and evaluation of response to PRRT. Current limitations and new perspectives, including artificial intelligence, are discussed.

Authors

Wolfgang Roll

Department of Nuclear Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
Matthias Weckesser

Department of Nuclear Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
Robert Seifert

Department of Nuclear Medicine, Medical Faculty, University Hospital Essen, Essen, Deutschland.
Lisa Bodei

Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kambiz Rahbar

Department of Nuclear Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany. rahbar@uni-muenster.de.

Keywords

Artificial Intelligence Humans Liquid Biopsy Neuroendocrine Tumors Octreotide Positron Emission Tomography Computed Tomography Prospective Studies Receptors, Somatostatin

External Resources

View on PubMed Access via DOI PubMed (33903926)

Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals